Skip to main content
Clinical Trials/NCT01422044
NCT01422044CompletedNot Applicable

Risk Prediction in Aortic Stenosis by Cardiac Autonomic Function

Thebiosignals.com1 site in 1 country423 target enrollmentStarted: September 2009Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
423
Locations
1
Primary Endpoint
Total mortality

Study Overview

Brief Summary

The purpose of this study is to test the prognostic value of autonomic markers in patients with aortic stenosis.

Detailed Description

Autonomic function will be assessed by presence of severe autonomic failure (defined by combination of abnormal heart rate turbulence and deceleration capacity).

Autonomic function will also be assessed by respiration and repolarization abnormalities.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Aortic valve area ≤1.5 qcm or mean aortic gradient ≥25mmHg

Exclusion Criteria

  • life expectancy <1 year due to non-cardiac causes

Outcomes

Primary Outcomes

Total mortality

Time Frame: 2 years

Secondary Outcomes

  • Cardiovascular mortality(2 years)
  • Combination of cardiovascular mortality and cardiac adverse events(2 years)
  • Correlation of presence of autonomic dysfunction with severity of aortic stenosis(at time of cardiac catheterization, which will be performed at an expected average of 3 days after hospital admission)

Investigators

Sponsor
Thebiosignals.com
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Axel Bauer

Prof. Dr. med. Axel Bauer

Thebiosignals.com

Study Sites (1)

Loading locations...

Similar Trials

Risk Prediction in Aortic Stenosis | Clinical Trial